Unclaimed Scholar Profile
Are you David O. Bates? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at South African Medical Research CouncilASIDASID-8374-8707-1720 orcid.org/0000-0003-4850-2360
David O. Bates
South African Medical Research Council•South Africa
Faculty researcher at South African Medical Research Council (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Angiogenesis and VEGF in Cancer#Lymphatic System and Diseases#Barrier Structure and Function Studies#Retinal Diseases and Treatments
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 16,228 | 7,789 |
| h-index | 70 | 53 |
| i10-index | 176 | 123 |
Annual Citation Growth
Verified Citations / Year0
2020779
2021+40%1.1k
2022+29%1.4k
2023+33%1.9k
2024-8%1.7k
2025-45%935
2026Scholarship Distribution & Proportions423 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (13,307) • 18% Global Research Impact (2,921)
423 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (423)
Hallmarks of alternative splicing in cancer
Published in Oncogene•2013
DOI: 10.1038/onc.2013.533 Verified Peer-Reviewed
Consensus guidelines for the use and interpretation of angiogenesis assays
Published in Angiogenesis•2018
DOI: 10.1007/s10456-018-9613-x Verified Peer-Reviewed
Cervical cancer in low and middle‑income countries (Review)
Published in Oncology Letters•2020
DOI: 10.3892/ol.2020.11754 Verified Peer-Reviewed
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Published in PubMed•2002
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Published in Nature reviews. Cancer•2008
DOI: 10.1038/nrc2505 Verified Peer-Reviewed
Showing 1 – 5 of 423 publications
1 / 85